OR WAIT null SECS
May 04, 2022
Accelerate Diagnostics’ new blood culture kit demonstrated 94% or greater accuracy on positive blood cultures relative to matrix-assisted laser desorption/ionization (MALDI).
May 03, 2022
FDA’s Office of Compliance has released its 2021 Annual Report, which highlights the agency’s successes in public health.
FDA has issued the final guidance on electronic postmarketing safety reports in a series of guidance documents.
VYDURA has been granted marketing authorization by the European Commission for both acute treatment of migraine and prophylaxis of episodic migraine.
May 02, 2022
Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.
A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.
ENHERTU has been granted breakthrough therapy designation in the US for patients with HER2 low metastatic breast cancer.
FDA has granted regenerative medicine advanced therapy (RMAT) designation to Autolus’ CAR-T cell therapy obe-cel.
April 29, 2022
Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.
A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet.